Tests treatments for diabetes, weight, and high cortisol levels
Part of Hormones & metabolism clinical trials.
This trial studies people who have type 2 diabetes and excess body weight, looking at how high cortisol (a stress hormone) may be involved. If you qualify, you may get a study treatment designed to improve diabetes and weight-related health by targeting cortisol-related pathways.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and also have excess body weight (obesity)
- You are not pregnant and are not breastfeeding
- You do not have sleep apnea
- You do not have symptoms that suggest high cortisol levels (hypercortisolism)
- Your kidneys are working well (no significant kidney disease, with low filtration rate excluded)
- You are not on medications that strongly affect cortisol or stress-hormone pathways
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how childhood trauma might affect stress hormones (cortisol) and inflammation in women with obesity. It aims to find connections that could lead to better treatments.
This is an observational study that follows generally healthy adults to understand how inflammation, diabetes (type 2), and weight/metabolic health relate to each other. It may help researchers figure out why different groups (including different ethnic backgrounds) have different health risks.
This trial tests a new medication, clofutriben, for people with hard-to-control type 2 diabetes who might also have mild excess of a stress hormone called cortisol. It aims to see if the drug can help lower blood sugar and improve diabetes management.
This study checks if a simple saliva test can find high cortisol levels in people with hard-to-control type 2 diabetes. It aims to help doctors identify if cortisol problems are making diabetes worse.
This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.
This study looks at adrenal nodules found on a CT scan and checks whether your cortisol levels stay high after a medication test. It may help researchers understand what causes abnormal cortisol production and how often it happens in people with adrenal growths.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.